Susine

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Susine

Property Description
Active ingredient Sulpiride
Form Oral Solid (Tablet/Capsule), Injectable Solution
Pharmacological class Benzamide Antipsychotic (Neuroleptic)
Common use Modulating mental and behavioral disturbances
Origin Synthetic

What Type of Medicine is Susine?

Susine is the commercial name for a prescription-only medication containing the active ingredient called Sulpiride, a compound officially registered as an International Nonproprietary Name (INN). Chemically, Sulpiride is classified as a substituted benzamide derivative. Medically, it is categorized within the high-level pharmacological class of Benzamide Antipsychotics, often grouped with neuroleptics. The compound is entirely synthetic in origin and functions as a single-active ingredient product (monotherapy). The use of Sulpiride, which has been available for decades, is clinically recognized for its differential effects on dopamine pathways compared to older neuroleptics.


What is the Composition and Form of Sulpiride?

The core composition of this medication is Sulpiride, a small molecule drug. Sulpiride-containing products are primarily supplied for oral administration in the form of oral solid forms, such as tablets or capsules, the typical form for patient use. For acute care settings requiring rapid effect, the active ingredient is also available as a sterile injectable solution for administration via the intramuscular route. Sulpiride's unique chemical structure, a benzamide, underlies its targeted action on specific dopamine receptors. This highlights that the drug's fundamental chemical structure dictates its ability to selectively modulate brain signaling.


What is the General Purpose of This Neuroleptic?

The general therapeutic purpose of this class of medication is to help re-establish balance in the brain's chemical communication pathways. Sulpiride achieves this fundamental action by functioning as a selective dopamine receptor antagonist, preferentially targeting the D2 and D3 subtypes. By regulating the activity of these receptors, the drug aims to normalize dysregulated dopaminergic signaling. This action supports the overarching goal of calming mental agitation and helping to restore stability to thought processes, which is typically applied in situations involving moderate to severe mental or behavioral disturbances.

What side effects are possible with Susine?

Possible Side Effects and Safety Information

The safety profile of Susine (Sulpiride) is documented by regulatory authorities, classifying possible adverse reactions primarily by frequency and the body systems involved. The drug’s safety information establishes specific restrictions and necessary monitoring required during use.

Documented Adverse Reactions and Frequency

Adverse reactions are classified according to their official documented frequency:

  • Common Reactions (affecting up to 1 in 10 patients) include hyperprolactinemia (increased prolactin hormone levels), weight gain, drowsiness, and extrapyramidal symptoms such as involuntary movements, tremors, and muscle stiffness (e.g., parkinsonism, acute dystonia, akathisia).
  • Uncommon Reactions (affecting up to 1 in 100 patients) include low white blood cell counts (leukopenia) and convulsions.
  • Rare Reactions (affecting up to 1 in 1,000 patients) include the specific cardiac arrhythmia known as Torsade de pointes.

Serious Safety Considerations

Regulatory documentation highlights the risk of several serious adverse reactions. These include the rare but severe Neuroleptic Malignant Syndrome (NMS), a potentially fatal reaction characterized by fever and muscle rigidity. Also documented are serious ventricular arrhythmias, including cardiac arrest and the risk of developing venous thromboembolism (VTE) (blood clots).

Safety Restrictions and Special Populations

Regulatory labels establish restrictions for use. The medication is contraindicated in patients with conditions such as Phaeochromocytoma and prolactin-dependent tumours. Regarding specific patient groups, the label notes that the dose may require adjustment for older adults with renal impairment. Furthermore, long-term exposure is specifically associated with the potential for tardive dyskinesia, an involuntary movement disorder.

Overdose and Emergency Response

Susine (cetirizine) overdose, while typically non-fatal, can cause significant distress and requires immediate medical evaluation. Cetirizine is a second-generation antihistamine, and an overdose usually involves exceeding the recommended daily dose, leading to enhanced side effects.

Signs and Symptoms of Overdose

The most common symptoms of Susine overdose in adults include drowsiness, rapid heartbeat (tachycardia), and headache. In children, an overdose may paradoxically cause agitation, restlessness, and irritability, in addition to drowsiness and rapid heartbeat. Other possible signs across all ages include confusion, difficulty walking, diarrhea, dilated pupils, and urinary retention. While not common, severe overdoses may, in rare cases, lead to collapse or altered mental status.

When to Seek Immediate Help

A Susine overdose is a medical concern, and professional guidance should be sought immediately, even if the individual appears well. Do not wait for symptoms to worsen.

Call emergency medical services immediately if the person:

  • Loses consciousness or becomes unresponsive.
  • Experiences a seizure.
  • Has severe difficulty breathing or irregular heart rhythm.
  • Exhibits extreme agitation or hallucinations.

For non-life-threatening but suspected overdose, contact a poison control center for expert advice on management and next steps. Medical treatment focuses on supportive care and monitoring of vital signs, and may include administering activated charcoal if ingestion was recent.

Therapeutic Uses of Susine

Main Therapeutic Uses of Susine

Susine is a pharmacological treatment primarily utilized for the management of specific endocrine and metabolic conditions. It is most commonly prescribed to address hormonal imbalances or deficiencies that require exogenous supplementation to restore physiological equilibrium.

Primary Indications

The medication is indicated for several clinical scenarios, including:

  • Hormone Replacement Therapy: Susine serves as a substitute in cases where the body does not produce sufficient levels of specific naturally occurring hormones. This helps in alleviating symptoms associated with endocrine insufficiency.
  • Growth and Development Support: In pediatric and adolescent populations, the medication may be used to address growth delays resulting from inadequate endogenous hormone production.
  • Metabolic Regulation: Susine plays a role in managing metabolic processes that are dependent on hormonal stability, ensuring that cellular functions and energy utilization remain within normal parameters.

Clinical Benefits

The therapeutic objective of Susine is to improve the patient’s quality of life by addressing the underlying hormonal deficit. The benefits observed during treatment typically focus on the stabilization of biological systems.

Physiological Improvements

  • Restoration of Hormonal Balance: By providing a consistent source of the necessary hormone, Susine helps stabilize the body’s internal environment.
  • Symptom Mitigation: Patients may experience a reduction in physical and fatigue-related symptoms that are often linked to endocrine disorders.
  • Support for Long-term Health: Maintaining appropriate hormonal levels is essential for bone density, cardiovascular health, and cognitive function, which can be supported through consistent therapy.

Developmental Outcomes

In cases involving growth-related indications, the medication assists in achieving a more typical growth velocity, helping patients reach developmental milestones that might otherwise be delayed due to hormonal gaps.

Eligibility and Restrictions for Use

Who Can and Cannot Use Susine?

Eligibility for Susine (Sulpiride) is strictly defined by regulatory guidelines, which establish absolute contraindications and population restrictions.


Absolute Non-Eligibility (Contraindications)

Susine must not be used by patients with the following conditions or associations:

  • Phaeochromocytoma (adrenal gland tumor) or Acute Porphyria.
  • Prolactin-dependent tumours (e.g., pituitary prolactinomas or breast cancer).
  • Known hypersensitivity to Sulpiride or its excipients.
  • Concomitant use with Levodopa (L-dopa).

Restricted or Conditional Use

Population Group Regulatory Status
Pediatric Patients (<14 years) Not recommended (Insufficient data and clinical experience).
Pregnant or Breastfeeding Women Not recommended (Potential risk to neonate and excretion into breast milk).
Older Adults Use with particular caution; dose reduction required if renal impairment is present.
Renal Impairment Use with caution (Dose must be reduced due to elimination pathway).
Cardiovascular Disorders Use with caution (Risk factors for QT interval prolongation must be monitored).
Epilepsy/Seizure History Use with caution (Potential to lower seizure threshold).

The eligible population is primarily adults for whom standard labeled indications are established. The use in certain groups is restricted due to either safety concerns or a lack of established efficacy data in regulatory documents.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Susine (Sulpiride) documents several specific interaction patterns classified by their potential effect.

Prohibited and Not Recommended Combinations

Co-administration with Levodopa and certain Antiparkinsonian drugs is officially contraindicated because of a reciprocal pharmacodynamic antagonism of effects. Furthermore, combining Sulpiride with many medications that affect the heart’s electrical activity is not recommended. This includes certain antiarrhythmic agents (Class Ia and III), bradycardia-inducing agents (like specific beta-blockers), and drugs that induce hypokalemia. These combinations are discouraged due to the additive pharmacodynamic risk of QT interval prolongation and Torsades de Pointes.


Pharmacokinetic and Additive Effects

Regulatory documents note that co-administration with Antacids (containing magnesium or aluminum) and Sucralfate decreases the absorption of Sulpiride, which can reduce plasma exposure. To manage this pharmacokinetic interference, Sulpiride must be administered two hours before these substances.

Additive effects are also documented with substances that depress the central nervous system. The consumption of alcohol is to be avoided as it enhances the sedative properties of Sulpiride. Combination with other CNS depressants or antihypertensive agents may result in enhanced effects such as sedation or postural hypotension. Regulatory information states Sulpiride does not significantly interact via the cytochrome P450 enzyme system.

Mechanism of Action

Selective Sodium Channel Modulation

Susine acts as a highly selective inhibitor by binding to the voltage-gated Na V1.8 sodium channels expressed primarily on peripheral sensory neurons. This mechanism stabilizes the channel in its closed, non-conducting state, engaging processes that regulate high-frequency electrical signaling within these cells.


Inhibition of Impulse Conduction

By preventing the Na V1.8 channel from opening in response to changes in membrane potential, Susine modifies the molecular steps required for initiating an action potential in the peripheral nervous system. This direct interaction results in the inhibition of impulse conduction within specific afferent neural pathways. The drug's activity is targeted to the peripheral nervous system due to the specific localization of the Na V1.8 channel, contributing to the modulation of impulse activity driven by distinct signaling patterns in these pathways.

Dosage and Administration Information

How to Use Susine: Administration Guidelines

This section outlines the standardized usage instructions for Sulpiride (Susine).


Administration Scope

Sulpiride is primarily administered via the oral route in tablet, capsule, or solution form. Tablets must be swallowed whole with water. The daily dose is generally given in two divided doses (e.g., morning and early evening) for psychiatric conditions. For schizophrenia, starting doses typically range from 400 mg to 800 mg daily, with a maximum of 2400 mg total daily reserved for the management of positive symptoms. Lower daily ranges (150 mg to 300 mg) are used for other indications, such as vertigo.

To ensure proper absorption, the medicine must be taken at least two hours before administering antacids or sucralfate. If a dose is forgotten, the instruction is to skip the missed dose if it is almost time for the next scheduled dose, and patients should never take a double dose to compensate.


Population and Course Management

Dose adjustments apply to specific populations. For patients with renal impairment, a dose reduction is required, with specific percentages or interval increases defined based on the degree of kidney function impairment. The use of the medicine is not recommended for children under 14 years of age due to insufficient clinical experience. Treatment management involves a defined initial phase followed by a maintenance period; when concluding therapy, the dosage must be slowly decreased before total withdrawal.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Susine


Evidence for Use in Schizophrenia Management

The research base for Sulpiride in managing symptoms related to schizophrenia includes various types of studies. Researchers have conducted Randomized Controlled Trials (RCTs), where Sulpiride was compared against an inactive placebo or other established compounds. The overall understanding of the evidence landscape also draws from systematic reviews that combine data from multiple RCTs, as well as large observational studies that track how the medicine is used over long periods in real-world settings.

Studies monitored several key aspects, including how symptoms like hallucinations and delusions (positive symptoms) were measured over time. Research also explored outcomes related to low motivation and social withdrawal (negative symptoms). Studies reported measurements related to these symptom axes, as well as observed changes in scales related to overall clinical status and daily-life functioning. These studies primarily included adults diagnosed with acute or chronic forms of the condition.

Evidence for Use in Acute Vertigo and Vestibular Syndromes

Sulpiride was also evaluated in studies examining its role in conditions characterized by episodic or acute manifestations, such as vertigo spells related to inner ear or balance issues. The research here includes randomized prospective studies comparing Sulpiride to other compounds evaluated for controlling vestibular symptoms.

Research examined outcomes related to physical discomfort, primarily focusing on the subjective intensity of acute vertigo as reported by patients on a scale. Studies also monitored outcomes related to physiological strain or stress by using specialized tests to measure balance function during the study period. Findings describe patterns observed in the studies conducted during periods of increased symptom activity.

Key Limitations and What Remains Uncertain About Susine

One key limitation is that evidence quality varies across studies, with a number of older trials having sample sizes that were modest and methodologies that do not meet current standards for reporting. Follow-up durations were limited for long-term, high-quality data on sustained functional outcomes and relapse prevention. The body of clinical experience and dedicated studies is limited for children under the age of 14 years and long-term effects are not fully established.

Frequently Asked Questions (FAQ)

Common questions about Susine (FAQ)


Q: Does Susine start working immediately or does it take a while?

Susine is absorbed by the body after a dose, and its half-life is around 6 to 8 hours. However, official patient information often indicates that it may take several weeks of regular administration before the full, intended benefits are observed for specific uses. This time is necessary for the drug to stabilize certain chemical pathways.


Q: How long does a dose of Susine typically last in the body?

Regulatory documents describe the elimination rate of the active ingredient, Sulpiride, using the term plasma half-life. The half-life is the time required for the amount of medicine in the blood to be reduced by half, and for Susine, this is approximately 6 to 8 hours.


Q: Can Susine affect my ability to focus or drive?

Yes, official safety information specifically warns that this medicine may affect your capacity for reaction and can impair your ability to drive or operate complex machinery. This effect can be enhanced if alcohol is consumed alongside the medicine. Patients are advised to use caution when performing skilled tasks.


Q: Is it true that Susine can cause changes in sleep patterns?

The regulatory safety profile for Susine lists drowsiness as a common side effect. Although not commonly reported, some official documents also note that insomnia (difficulty sleeping) has been described, particularly in people who stop taking the medicine suddenly.


Q: Does Susine have to be taken at a specific time of day?

For certain purposes, the administration guidelines recommend dividing the daily dose into two, such as one in the morning and one in the early evening. This approach is part of the standard usage instructions.


Q: Do I need any special tests or monitoring while taking Susine?

Regulatory documents advise on monitoring specific health indicators, especially in certain patient groups or if side effects occur. This may involve monitoring hormone and electrolyte levels, performing an ECG (heart tracing), and checking for proper kidney and liver function using blood tests.


Q: What happens if I suddenly stop taking Susine?

Official guidance emphasizes that the medication should be gradually decreased only under medical supervision. Abrupt cessation may lead to acute withdrawal symptoms, which are described as potentially including nausea, vomiting, sweating, and insomnia, or the emergence of involuntary movement disorders.


Q: Is it possible to become dependent on Susine?

Official product information does not classify the active ingredient, Sulpiride, as an addictive or dependence-causing substance. However, regulatory documents stress the necessity of a gradual withdrawal to avoid the acute discontinuation symptoms that can occur when the drug is stopped suddenly.


Q: Is Susine used for anything other than [main use]?

Beyond its primary role in modulating mental and behavioral disturbances, official indications from various global regions list other approved uses, which can include the management of conditions causing vertigo and, in some countries, major depressive disorder.


Q: Does Susine affect blood pressure?

Official documents list postural hypotension (a form of low blood pressure that occurs upon standing up) as a possible side effect. Patients with frequent occurrences of this effect are typically monitored by a healthcare professional.


Q: Is Susine likely to cause weight gain or weight loss?

Official regulatory documents list weight gain as a Common Reaction (affecting up to 1 in 10 patients) associated with the use of Sulpiride. Weight loss is not typically listed as a common or uncommon side effect in the official safety profile.


Q: Are there any dietary restrictions to follow while on Susine?

The official label does not mandate restrictions on general food consumption. However, regulatory documents state that the consumption of alcohol is to be avoided because it enhances the medicine's sedative effects. Also, the dose must be separated by at least two hours from antacids.


Q: What is the evidence level for Susine's main use?

Official regulatory summaries confirm that the evidence base supporting the drug's established indications is drawn from high-level research. This includes formal studies like Randomized Controlled Trials (RCTs) and systematic reviews that combine data from multiple studies.


Q: Is Susine a controlled substance?

The active ingredient, Sulpiride, is not typically classified as a 'controlled substance' in standard international drug scheduling (like the U.S. DEA schedule). However, it is officially categorized as an Antipsychotic and is a prescription-only medicine.


Q: Can taking Susine cause headaches?

Headaches are a possible side effect of many medications. While headaches are not officially documented as a common or uncommon adverse reaction in the regulatory safety profile for Susine, like any medicine, its use may be associated with side effects not listed with a specific frequency.


Q: Does Susine affect hormones?

Yes, regulatory documents describe that Susine can affect hormone levels. It lists hyperprolactinemia (increased levels of the hormone prolactin) as a Common Reaction. Due to this potential effect, the drug is contraindicated (must not be used) in patients with prolactin-dependent tumours.


Q: Can Susine interact with over-the-counter pain relievers?

Regulatory documents do not specifically name individual OTC pain relievers. However, official guidance is to always inform your doctor or pharmacist about all medicines and supplements you are taking, as certain combinations may be unsuitable.


Q: What should I do if I think Susine is not working?

Official patient information advises that if there are concerns about the medicine's effectiveness, you should contact your prescribing doctor for a review and avoid making any changes to the dose independently.


Q: Can people with liver problems safely use Susine?

Official guidance notes that since the drug is weakly metabolized by the liver, a routine dosage adjustment is not typically necessary for patients with mild liver insufficiency. However, those with a history of severe liver problems should ensure this is discussed with their medical professional.


Q: Is Susine available worldwide under the same name?

No. The active compound is known internationally by its official name, Sulpiride (the International Nonproprietary Name, or INN). However, the commercial name, such as Susine, which the patient receives, varies significantly depending on the country or region where the medicine is marketed.


Q: Does Susine have a black box warning from the FDA?

The active ingredient, Sulpiride, is not currently approved for use or marketing by the U.S. Food and Drug Administration (FDA). Therefore, the specific FDA safety mandate known as a 'black box warning' does not apply to this drug.


Q: Why are people often told to avoid grapefruit with certain medications, and is this true for Susine?

Grapefruit can interfere with the breakdown of many drugs by affecting certain enzymes (the P450 system). Official regulatory information for Sulpiride advises that the drug does not significantly interact via this enzyme system, making the general grapefruit warning less relevant for this specific medicine.


Q: Why is Susine sometimes stopped after a period of time?

Regulatory guidance indicates that treatment involves continuous review after an initial phase. Authorities note that long-term exposure is associated with the potential for developing tardive dyskinesia (an involuntary movement disorder), which may lead to a clinical management review.


How should Susine be stored and disposed of?

Official Storage and Disposal Instructions

The storage and disposal instructions for the medication containing Sulpiride (Susine) are precisely defined in the official regulatory documents to ensure product integrity and public safety.

Storage Conditions

Requirement Official Instruction
Temperature Do not store above 25 C (for the oral solid form).
Protection Should be Protected from light to maintain stability.
Packaging Keep the medicine in its original container.
Child Safety Must be kept out of the sight and reach of children.

Disposal Rules

To prevent environmental contamination, official regulatory guidance states that unused or expired Sulpiride must not be disposed of via wastewater or ordinary household waste. Instead, the unwanted medicine should be returned to a pharmacist. The pharmacist will ensure that the product is handled and disposed of according to established pharmaceutical waste procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Susine found in:

A-Z Index: